Abstract
Alzheimer’s disease (AD) is one of the major neurodegenerative diseases whose underlying risk factors are yet to be fully understood. However, reduced cellular level of cholinesterase, as well as formation and deposition of amyloid plaques (Aβ) are thought to play critical roles in the pathogenesis of AD. Therefore, increases in cholinergic transmitter levels via cholinesterase (ChE) inhibitors as well as inhibition of amyloid plaques formation and aggregation via beta secretase-1 (BACE1) inhibitors have been proposed as treatment for this disease. This study was aimed at investigating the BACE1 and ChE inhibitory properties of compounds from Cajanus cajan and Citrus reticulata based on their traditional connection with the management of neurodegenerative diseases, coupled with their protective effects on chemical-induced cognitive impairment. Using in silico methods, one hundred and nineteen compounds from C. cajan and C. reticulata were docked with acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and BACE1 using Vina. Molecular interactions of the top-ranked compounds for the 3 protein targets were viewed with Discovery Studio, followed by characterization of their ADME properties using the Swiss online ADME web tool. Among the one hundred and ninety nine compounds screened, 3 compounds, genistin (76), naphthalen-2-yl-acetic acid, 6-hydroxy-6-methyl-cyclodecyl ester (94) and vitexin (119) have remarkable binding affinity for the three protein targets and passed the oral drugability test, while only naphthalen-2-yl-acetic acid, 6-hydroxy-6-methyl-cyclodecyl ester (94) exhibited BBB permeation property. Genistin and vitexin from C. cajan and naphthalen-2-yl-acetic acid, 6-hydroxy-6-methyl-cyclodecyl ester from C. reticulata possibly contributed, at least in part, to the neurotherapeutic potentials of these plants.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ademosun AO, Oboh G (2014) Anticholinesterase and antioxidative properties of water-extractable phytochemicals from some citrus peels. J Basic Clin Physiol Pharmacol 25:199–204. https://doi.org/10.1515/jbcpp-2013-0027
Ahmad A, Ramasamy K, Bakar A et al (2015) Enhancement of b-secretase inhibition and antioxidant activities of tempeh, a fermented soybean cake through enrichment of bioactive aglycones. Pharm Biol 53:758–766. https://doi.org/10.3109/13880209.2014.942791
Ahmad L, Mishra A, Rahman A (2019) Protective role of hydroalcoholic extract of Cajanus cajan Linn leaves against memory impairment in sleep deprived experimental rats. J Ayurveda Integr Med. https://doi.org/10.1016/j.jaim.2018.08.003
Arbel-Ornath M, Hudry E, Boivin JR et al (2017) Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain. Mol Neurodegener 12:1–14. https://doi.org/10.1186/s13024-017-0169-9
Bartolucci C, Perola E, Pilger C et al (2001) Three-dimensional structure of a complex of galanthamine (Nivalin®) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs. Proteins Struct Funct Genet 42:182–191. https://doi.org/10.1002/1097-0134(20010201)42:2<182::AID-PROT50>3.0.CO;2-1
Bell EW, Zhang Y (2019) DockRMSD: an open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism. J Cheminform 11:1–9. https://doi.org/10.1186/s13321-019-0362-7
Borah K, Sharma S, Silla Y (2019) Structural bioinformatics-based identification of putative plant based lead compounds for Alzheimer Disease Therapy. Comput Biol Chem 78:359–366. https://doi.org/10.1016/j.compbiolchem.2018.12.012
Daina A, Zoete V (2016) A BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 11:1117–1121
Daina A, Michielin O, Zoete V (2014) ILOGP: a simple, robust, and efficient description of n-octanol/water partition coefficient for drug design using the GB/SA approach. J Chem Inf Model 54:3284–3301. https://doi.org/10.1021/ci500467k
Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https://doi.org/10.1038/srep42717
Ganai SA, Shanmugam K, Mahadevan V (2015) Energy-optimised pharmacophore approach to identify potential hotspots during inhibition of class II HDAC isoforms. J Biomol Struct Dyn 33:374–387. https://doi.org/10.1080/07391102.2013.879073
Gleeson M, Hersey A, Hannongbua S (2011) In-silico ADME models: a general assessment of their utility in drug discovery applications. Curr Top Med Chem 11:358–381. https://doi.org/10.2174/156802611794480927
Gopinath K, Sudhandiran G (2012) Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway. Neurosci 227:134–143
Gorinstein S, Mart´ın-Belloso O, Park YS (2001) Comparison of some biochemical characteristics of different citrus fruits. Food Chem 74:309–315
Gro JK, Yada S, Vats V (2002) Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol 81:81–100
Henry W, Querfurth HW, LaFerla FM (2010) Mechanisms of disease Alzheimer’s disease. New Engl J Med 362:329–344
Ijaopo E (2017) Dementia-related agitation: a review of non-pharmacological interventions and analysis of risks and benefits of pharmacotherapy. Transl Psychiatry 7:e1250–e1250
Ishola AA, Adewole KE (2019) In silico screening of anticholinesterase alkaloids for cyclooxygenase-2 (COX-2) and matrix metalloproteinase 8 (MMP-8) inhibitory potentials as multi-target inhibitors of Alzheimer’s disease. Med Chem Res 28:1704–1717. https://doi.org/10.1007/s00044-019-02407-4
Jannat S, Balupuri A, Ali MY et al (2019) Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure – activity relationship with a strong BBB permeability. Exp Mol Med 51:1–18. https://doi.org/10.1038/s12276-019-0205-7
Johansson P, Kaspersson K, Gurrell IK et al (2018) Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity. J Med Chem 61:3491–3502. https://doi.org/10.1021/acs.jmedchem.7b01716
Jung HA, Karki S, Kim JH, Choi JS (2015) BACE1 and cholinesterase inhibitory activities of Nelumbo nucifera embryos. Arch Pharm Res 38:1178–1187. https://doi.org/10.1007/s12272-014-0492-4
Kandalepas PC, Sadleir KR, Eimer WA et al (2013) The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques. Acta Neuropathol 126:329–352. https://doi.org/10.1007/s00401-013-1152-3
Kumar V, Bhatt CP, Shruti P, Panda PB (2017) Attenuation of neurobehavioral and neurochemical abnormalities in animal model of cognitive deficits of Alzheimer ’ s disease by fermented soybean nanonutraceutical. Inflammopharmacology 26:105–118. https://doi.org/10.1007/s10787-017-0381-9
Lipinski CA (2000) Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 44(1):235–249
Luo M, Liu X, Zu Y et al (2010) Cajanol, a novel anticancer agent from Pigeonpea [ Cajanus cajan (L.) Millsp.] roots, induces apoptosis in human breast cancer cells through a ROS-mediated mitochondrial pathway. Chem Biol Interact 188:151–160. https://doi.org/10.1016/j.cbi.2010.07.009
Malar DS, Shafreen RB, Pandian SK, Devi KP (2017) Cholinesterase inhibitory, anti-amyloidogenic and neuroprotective effect of the medicinal plant Grewia tiliaefolia -— An in vitro and in silico study. Pharm Biol 55:381–393. https://doi.org/10.1080/13880209.2016.1241811
Malar DS, Suryanarayanan V, Prasanth MI, Singh SK, Krishnaswamy Balamurugan KPD (2018) Vitexin inhibits Aβ25–35 induced toxicity in Neuro-2a cells by augmenting Nrf-2/HO-1 dependent antioxidant pathway and regulating lipid homeostasis by the activation of LXR-α. Toxicol Vitr 50:160–171. https://doi.org/10.1016/j.tiv.2018.03.003
McConkey BJ, Sobolev V, Edelman M (2002) The performance of current methods in ligand-protein docking. Curr Sci 83:845–855
Meng X-Y, Zhang H-X, Mezei M, Meng C (2011) Molecular Docking: a powerful approach for structure-based drug discovery. J Curr Comput Aided Drug Des 7:146–157
Molinuevo JL, Gispert JD, Dubois B (2013) The AD-CSF-index discriminates Alzheimer’s disease patients from healthy controls: a validation study. J Alzheimers Dis 36:67–77
Morphy R, Rankovic Z (2005) Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem 48:6523–6543. https://doi.org/10.1021/jm058225d
Murphy PM, LeVine H (2010) Alzheimer’s disease and the β-Amyloid Peptide. J Alzheimers Dis 19:311
Nicolet Y, Lockridge O, Masson P et al (2003) Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products. J Biol Chem 278:41141–41147. https://doi.org/10.1074/jbc.M210241200
Ogura H, Kosasa T, Kuriya Y, Yamanishi Y (2000) Comparison of inhibitory activities of donepezil and other cholinesterase inhi- bitors on acetylcholinesterase and butyrylcholinesterase in vitro. Methods Find Exp Clin Pharmcol 22:609–613
Qin K, Zheng L, Cai H et al (2013) Characterization of Chemical Composition of Pericarpium Citri Reticulatae Volatile Oil by Comprehensive Two-Dimensional Gas Chromatography with High-Resolution Time-of-Flight Mass Spectrometry. Evidence-Based Complement Altern Med 2013:1–12
Rao AA, Sridhar GR, Das UN (2007) Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer’s disease. Med Hypotheses 69:1272–1276. https://doi.org/10.1016/j.mehy.2007.03.032
Ruan CJ, Si JY, Zhang L et al (2009) Protective effect of stilbenes containing extract-fraction from Cajanus cajan L. on Aβ 25–35 -induced cognitive deficits in mice. Neurosci Lett 467:159–163. https://doi.org/10.1016/j.neulet.2009.10.029
Schuster R, Holzer W, Doerfler H et al (2016) Cajanus cajan -a source of PPARγ activators leading to anti-inflammatory and cytotoxic effects. Food Funct 7:3798–3806. https://doi.org/10.1039/c6fo00689b
Seki T, Kamiya T, Furukawa K et al (2013) Nobiletin-rich Citrus reticulata peels, a kampo medicine for Alzheimer’s disease: a case series. Geriat Gerontol Int 13:236–238
Sugimoto H, Ogura H, Arai Y et al (2002) Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor. Jpn J Pharmacol 89:7–20
Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461
Vassar R (2002) β-secretase (BACE) as a drug target for Alzheimer’s disease. Adv Drug Deliv Rev 54(12):1589–1602. https://doi.org/10.1016/S0169-409X(02)00157-6
Walters W, Stahl MT, Murcko MA (1998) Virtual screening an overview. Drug Discov Today 3:160–178
Wang L, Tao X, Liu X et al (2019) Cajaninstilbene acid ameliorates cognitive impairment induced by intrahippocampal injection of amyloid-β1–42 oligomers. Front Pharmacol 10:1–18. https://doi.org/10.3389/fphar.2019.01084
Willén K, Edgar JR, Hasegawa T et al (2017) Aβ accumulation causes MVB enlargement and is modelled by dominant negative VPS4A. Mol Neurodegener 12:1–18. https://doi.org/10.1186/s13024-017-0203-y
Yan R, Blenkowski MJ, Shuck ME et al (1999) Membrane-anchored aspartyl protease with Alzheimer’s disease β- secretase activity. Nature 402:533–537. https://doi.org/10.1038/990107
Zaheer K, Akhtar MH (2017) An updated review of dietary isoflavones: nutrition, processing, bioavailability and impacts on human health. Crit Rev Food Sci Nutr 57:1280–1293. https://doi.org/10.1080/10408398.2014.989958
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declared that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Adewole, K.E., Ishola, A.A. BACE1 and cholinesterase inhibitory activities of compounds from Cajanus cajan and Citrus reticulata: an in silico study. In Silico Pharmacol. 9, 14 (2021). https://doi.org/10.1007/s40203-020-00067-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s40203-020-00067-6